WallStSmart

Fortrea Holdings Inc. (FTRE)vsInsmed Inc (INSM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Fortrea Holdings Inc. generates 349% more annual revenue ($2.72B vs $606.42M). INSM leads profitability with a -2.1% profit margin vs -36.2%. FTRE appears more attractively valued with a PEG of 0.34. FTRE earns a higher WallStSmart Score of 45/100 (D).

FTRE

Hold

45

out of 100

Grade: D

Growth: 2.0Profit: 4.0Value: 6.7Quality: 3.0
Piotroski: 3/9Altman Z: 0.15

INSM

Hold

39

out of 100

Grade: F

Growth: 6.0Profit: 2.0Value: 6.7Quality: 6.3
Piotroski: 6/9Altman Z: -3.77

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

FTRE3 strengths · Avg: 9.3/10
PEG RatioValuation
0.3410/10

Growing faster than its price suggests

Operating MarginProfitability
133.0%10/10

Strong operational efficiency at 133.0%

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

INSM0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

FTRE4 concerns · Avg: 2.5/10
Market CapQuality
$882.64M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-102.4%2/10

ROE of -102.4% — below average capital efficiency

Revenue GrowthGrowth
-5.2%2/10

Revenue declined 5.2%

INSM4 concerns · Avg: 3.0/10
Revenue GrowthGrowth
1.5%4/10

1.5% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Price/BookValuation
43.0x2/10

Trading at 43.0x book value

Return on EquityProfitability
-2.5%2/10

ROE of -2.5% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : FTRE

The strongest argument for FTRE centers on PEG Ratio, Operating Margin, Price/Book. PEG of 0.34 suggests the stock is reasonably priced for its growth.

Bull Case : INSM

PEG of 1.09 suggests the stock is reasonably priced for its growth.

Bear Case : FTRE

The primary concerns for FTRE are Market Cap, Piotroski F-Score, Return on Equity. Debt-to-equity of 2.04 is elevated, increasing financial risk.

Bear Case : INSM

The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.

Key Dynamics to Monitor

FTRE carries more volatility with a beta of 1.78 — expect wider price swings.

INSM is growing revenue faster at 1.5% — sustainability is the question.

FTRE generates stronger free cash flow (122M), providing more financial flexibility.

Monitor BIOTECHNOLOGY industry trends, competitive dynamics, and regulatory changes.

Bottom Line

FTRE scores higher overall (45/100 vs 39/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Fortrea Holdings Inc.

HEALTHCARE · BIOTECHNOLOGY · USA

Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. The company is headquartered in Durham, North Carolina.

Visit Website →

Insmed Inc

HEALTHCARE · BIOTECHNOLOGY · USA

Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.

Want to dig deeper into these stocks?